Brachytherapy

Papers
(The H4-Index of Brachytherapy is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation26
First clinical implementation of GammaTile permanent brain implants after FDA clearance25
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement23
The American Brachytherapy society consensus statement for skin brachytherapy22
Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective21
Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies21
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas21
Conventional vs machine learning–based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial21
Very accelerated partial breast irradiation Phase I–II multicenter trial (VAPBI): Feasibility and early results20
A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer20
American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers19
Virtual reality-based simulation improves gynecologic brachytherapy proficiency, engagement, and trainee self-confidence19
End-to-end delivery quality assurance of computed tomography–based high-dose-rate brachytherapy using a gel dosimeter18
Simulation-based learning for enhanced gynecologic brachytherapy training among radiation oncology residents16
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control15
Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives15
0.070490837097168